-+ 0.00%
-+ 0.00%
-+ 0.00%

MERCK & CO - SAC-TMT PHASE 3 TRIAL SHOWS IMPROVED SURVIVAL IN ENDOMETRIAL CANCER

Reuters·10/13/2026 10:45:00

Please log in to view news